USD 23.15
(-1.53%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 173.4 Million USD | -42.77% |
2022 | 302.98 Million USD | -21.53% |
2021 | 386.12 Million USD | 467.13% |
2020 | -105.17 Million USD | -128.56% |
2019 | 368.2 Million USD | -13.88% |
2018 | 427.54 Million USD | 17.57% |
2017 | 363.63 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 32.96 Million USD | -20.38% |
2024 Q2 | 30.56 Million USD | -7.29% |
2024 Q3 | -338.21 Million USD | -1206.53% |
2023 Q4 | 41.4 Million USD | 4.78% |
2023 FY | 173.4 Million USD | -42.77% |
2023 Q3 | 39.51 Million USD | 13.86% |
2023 Q2 | 34.7 Million USD | -26.07% |
2023 Q1 | 46.94 Million USD | 136.83% |
2022 Q3 | 36.39 Million USD | -62.77% |
2022 Q2 | 97.76 Million USD | -16.18% |
2022 Q1 | 116.63 Million USD | 6.42% |
2022 FY | 302.98 Million USD | -21.53% |
2022 Q4 | 19.82 Million USD | -45.54% |
2021 Q4 | 109.6 Million USD | 4.93% |
2021 Q3 | 104.45 Million USD | 16.31% |
2021 Q2 | 89.8 Million USD | 9.16% |
2021 Q1 | 82.26 Million USD | 167.91% |
2021 FY | 386.12 Million USD | 467.13% |
2020 Q1 | 87.61 Million USD | -14.67% |
2020 Q4 | -121.14 Million USD | 41.56% |
2020 Q3 | -207.28 Million USD | -1122.58% |
2020 Q2 | 20.27 Million USD | -76.86% |
2020 FY | -105.17 Million USD | -128.56% |
2019 Q3 | 81.1 Million USD | -12.04% |
2019 Q1 | 92.21 Million USD | 0.0% |
2019 FY | 368.2 Million USD | -13.88% |
2019 Q4 | 102.67 Million USD | 26.59% |
2019 Q2 | 92.21 Million USD | 0.0% |
2018 FY | 427.54 Million USD | 17.57% |
2017 FY | 363.63 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
American Well Corporation | -692.14 Million USD | 125.053% |
Doximity, Inc. | 163.87 Million USD | -5.813% |
Evolent Health, Inc. | -71.21 Million USD | 343.507% |
Phreesia, Inc. | -131.77 Million USD | 231.593% |
Teladoc Health, Inc. | -248.55 Million USD | 169.765% |
Veeva Systems Inc. | 429.33 Million USD | 59.611% |